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Summary. The expression of glypican-3 (GPC3), a 
heparan-sulfate proteoglycan associated with the 
Simpson-Golabi-Behmel fetal overgrowth syndrome, 
was studied in normal human placental tissue and cell 
lines derived from human placentae. Cytotrophoblasts 
derived from term placentae expressed GPC3 mRNA at 
low levels in culture. GPC3 mRNA expression increased 
markedly during trophoblast differentiation. By contrast, 
fibroblast cell lines derived from normal placentae did 
not express GPC3 in culture. Similarly, choriocarcinoma 
cell lines derived from human placentae (BeWo, JAR, 
and JEG) failed to express GPC3 mRNA. In situ 
hybridization confirmed the localization of GPC3 
mRNA to the syncytiotrophoblast.  Furthermore, 
immunohistochemical staining of paraffin imbedded 
placental tissue demonstrated intense staining of the 
syncytiotrophoblast cell layer and less intense staining of 
cytotrophoblasts. No staining of mesenchymal elements 
was noted. These data confirm the presence of GPC3 in 
human placenta and suggest it is expressed by the 
differentiated syncytiotrophoblast at term. 
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lntroduction 
Glypican-3 (GPC3) is a recently identified heparan- 
sulfate proteoglycan associated with the Simpson- 
Golabi-Behmel (SGB) fetal overgrowth syndrome (Pilia 
et al., 1996; Pellegrini et al., 1998). GPC3 is located on 
the X chromosome and expressed primarily in 
embryonic tissue, including the placenta. SGB shares 
phenotypic similarities with the Beckwith-Weidemann 
and Perlman Syndromes, including the increased risk for 
the development of embryonal tumors (Neri et al., 1998; 
Veugelers et al., 1998). The physiological role of GPC3 
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has not been clearly defined but severa1 important 
observations have provided some potentially significant 
insights.  Pilia and colleagues (1996) originally 
demonstrated that GPC3 could bind IGF-11 suggesting it 
could serve, in part, as an important modulator of local 
IGF-11 levels andlor processing. Modulation of the 
biological activity of locally expressed IGF-11 is 
intriguing given the phenotypic overlap of SGB with 
Beckwith-Weidemann Syndrome (BWS) and the 
overexpression of IGF-11 associated with those patients 
(Hedborg et al., 1994). Subsequent reports looking 
specifically at OCI-5, the rat homologue of GPC3, failed 
to  demonstrate IGF-11 binding activity but did 
demonstrate its ability to bind FGF (Song et al., 1997). 
More recently, high levels of immunoreactive GPC3 
capable of binding IGF-11 have been demonstrated in 
human amniotic fluid, providing further support for a 
role at the maternal-fetal interface (Xu et al., 1998). 
However, the source of amniotic fluid GPC3 has not 
been identified. 
Normal placental growth and function is essential for 
embryonic development. The syncytiotrophoblast is the 
placental cell associated with functions known to be 
critica1 to fetal well-being, i.e. nutrient transport, gas 
exchange, and hormone production. The expression of 
this functional activity is  dependent on the normal 
growth of the cytotrophoblast and its differentiation into 
the mature syncytiotrophoblast.  In addition, the 
interactions of the trophoblast with the adjacent stromal 
compartment and maternal decidua are important 
determinants of its developmental program. These 
interactions are dependent, in part, on the cell-specific 
expression of specific growth factors including the 
insulin-like growth factors. Both IGF-1 and IGF-11 are 
expressed by the placenta in a cell-specific manner 
throughout gestation suggesting important paracrine 
mechanisms of action (Fant et al., 1986; Wang et al., 
1988; Ohlsson et al., 1989). We have developed in vitro 
models to study the role of IGFs in the regulation of 
placental growth utilizing both trophoblasts and 
placental fibroblasts (Fant, 1991; Cohran et al., 1996; 
Fang et al., 1997). Placental GPC3 is likely to play a 
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significant role in placental growth, in part, by 
interacting with speciñc peptide growth factor signaling 
pathways. Nothing is known regarding the mechanisms 
of GPC3 action at the cellular level. We undertook these 
studies to determine the cell-specific expression of 
GPC3 in the human placenta in order to begin to study 
its role in placental development. 
Materials and methods 
Sources of materials 
Human placentae were obtained from normal, 
uncomplicated pregnancies in accordance with a 
protocol approved by UT-Houston Health Science 
Center, Houston, Texas, and Washington University 
School of Medicine, St. Louis, MO, Rabbit, polyclonal 
anti-GPC3 antiserum was generated by Research 
Genetics against a polypeptide fragment of the GPC3 
protein and affinity purified. Four distinct peptides from 
the predicted GPC3 primary amino acid sequence, N- 
RKMEEKYQLTAR, N-RHAKNYTNAMFK, N- 
EIDKYWREYIL, and N-AHSQQRQYRSAYY were 
produced by Research Genetics (Huntsville, AL) 
according to standard peptide synthesis protocols. Al1 
were conjugated to 8-MAP and injected into New 
Zealand white rabbits (3-9 months of age) in three 
subcutaneous dorsal s i tes  a t  0.5 mg peptide per 
immunization on day 0, week two, and week six, also 
according to standard protocols. Serum was collected 
every 2-4 weeks and tested for activity against the 
peptide pools. Antibody titer was determined using an 
ELISA with free peptide bound in solid phase (1  
pdwell). Those bleeds producing the highest titers were 
purified using using a HiTrap protein G column 
(Pharmacia) according to the manufacturer's instructions. 
Epitope mapping was performed on this purified 
antibody pool using a slot blot containing al1 four 
individual peptides that comprised the initial 
immunogen. These slot blot results indicated that the 
polyclonal antibody was efficiently recognizing 3 of the 
4 peptides. The antibody was then affinity purified using 
the peptide antigens immobilized on an activated 
support. The human GPC3 cDNA probe is a 2.1 kb 
insert containing the entire reading £rame contained in a 
Bluescript transcription vector (Stratagene) at the EcoRl 
cloning site. 
lsolation and culture of normal trophoblasts 
Cytotrophoblasts were isolated from normal, human 
placentae by enzymatic dispersion with trypsin and 
isolated on a percoll gradient as previously described 
(Moe et al., 1991). Resulting trophoblast cultures were 
>95% pure as assessed by cytokeratin positivity. These 
cells spontaneously differentiate over 72 hours in culture 
to form syncytiotrophoblasts as  assessed by 
characteristic morphological changes and the expression 
of differentiation state-specific markers, i.e. pregnancy- 
specific B 1  glycoprotein (SP1) and human placental 
lactogen (Kliman et al., 1986). Placental fibroblasts were 
obtained from normal placental tissue by enzymatic 
dispersion and characterized by analysis of cell-specific 
markers to exclude the presence of differentiated 
endothelial cells, vascular smooth muscle cells, and 
trophoblasts. The isolation and characterization of these 
cells have been described in detail (Fant, 1991). 
Northern analyisis of GPC3 
Total RNA was prepared from normal trophoblasts 
and choriocarcinoma cells by a modification of the 
method described by (Chomczynski and Sacchi, 1987). 
Poly A enriched RNA was obtained by oligo-dT 
chromatography. The  RNA samples were size 
fractionated by electrophoresis on a 1.5% agarose gel 
containing 0.6M formaldehyde and transferred to Nylon 
+ membranes (Amersham) for hybridization. Prior to 
hybridization the membranes were washed in 2 x SSC 
for 5 minutes. 
A 2.1 kb insert of human GPC-3 was prepared and 
labeled by random primer hexamer method using [a -  
3 2 ~ ] d ~ ~ ~  (Amersham, Arlington Heights, 11). 
Prehybridization and hybridization were carried out for 
30 minutes and 1 hour, respectively, in hybridization 
buffer (ExpressHyb - Clontech) for 1 hour at 65 The 
membrane was then washed 4 x 10 min. at 22 QC in 2 x 
SSC, 0.05% SDS, and 2 x 20 min at 50 *C in 0.1 x SSC, 
0.1% SDS. Thereafter the blots were stripped and 
rehybridized with cDNA probes for human 8-actin and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
ln situ hybridization 
Term placental tissue was collected and fixed 
overnight in 10% buffered formalin. After washing in 
fresh PBS, fixed tissues were dehydrated, cleared and 
embedded in paraffin by routine methods. Sections (5 
pm) were collected on Superfrostlplus positively- 
charged microscope slides (Fisher Scientific, Pittsburgh 
PA), deparaffinized, and in situ hybridization carried out 
according to established protocols (Albrecht et al., 
1997). The full-length cDNA for human GPC3 was used 
to generate riboprobes used for detection. Riboprobes 
were labeled with [ a - 3 5 ~ ] ~ ~ ~ .  To generate GPC3 the 
antisense riboprobe, the plasmid was linearized with 
XhoI and transcribed with T3 RNA polymerase. The 
sense riboprobe was generated by linerarizing plasmid 
with XbaI followed by transcription with T7 RNA 
polymerase. Samples were overlayed with 4 million 
counts of antisense or sense riboprobe and hybridized 
overnight at 60 OC. Post-hybridization washes were 
carried out as described (Albrecht et al., 1997), and 
slides were dipped in Kodak NTB-2 emulsion and 
exposed for three days. Sections were viewed and 
photographed using an Olympus BX60 microscope 
equipped with a SPOT digital camera (Diagnostics 
Instruments, Sterling Heights, MI). 
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1990). Unlike normal trophoblasts, these cells failed to 
express GPC3 mRNA in the undifferentiated state or 
during forskolin-stimulated differentiation (Fig. 2). 
GPC3 mRNA expression in Caco-2 and HeLa cells is 
included as positive and negative controls, respectively 
(Pilia et al., 1996). These results suggest that the normal 
syncytiotrophoblast expresses GPC3 and that expression 
is coupled to cell differentiation. 
Localization of GPC3 mRNA by In Situ Hybridization 
To further define the cellular localization of GPC3 
transcripts in the term human placenta, in situ 
hybridization was carried out using an antisense 
riboprobe specific for GPC3 (Fig. 3). High levels of 
GPC3 transcript were detected in the syncytiotrophoblast 
layer of the chorionic villi of placentae hybridized with 
the antisense GPC3 riboprobe (Fig. 3A), whereas no 
hybridization signal was detected in a serial section 
hybridized with sense GPC3 riboprobe (Fig. 3B). The 
intensity of the signal appeared rather weak in some villi 
relative to others suggesting variable expression in some 
villous segments. These data are representative of three 
different placentae and confirm the expression of GPC3 
mRNA by the syncytiotrophoblast and the lack of 
expression by mesenchymal elements. 
lmmunohistochemical localization of placental GPC3 
Immunohistochemical analysis of paraffin-imbedded 
tissue sections of term placentae also revealed specific 
staining confined to the syncytiotrophoblast in the 
chorionic villi (Fig. 4), consistent with the localization of 
GPC3 mRNA and expression in cultured cells. While the 
staining was intensely localized to the syncytiotro- 
phoblast of the chorionic villi, its distribution was not 
uniform since neighboring villi appeared to be stained 
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Flg. 2. Northern analysis of GPC3 mRNA expression by 10 week 
placental fibroblasts and choriocarcinoma cell lines. rnRNA was 
obtained from ea& cell line just prior to reaching confluente. mRNA 
was obtained frorn the b30 done of the BeWo cell line after 24 and 48 
hours of forskolin (100 pM) treatment to induce cell differentiation. JEG 
and JAR choriocarcinorna cell lines were not treated with forskolin. 
Fibro: placental fibroblast cell line. Analysis of Caco-2 and HeLa cell 
expression is included as positive and negative controls, respect'iely. 
l ess  intensely (Fig. 4A). The  underlying cyto- 
trophoblasts exhibited less intense staining (Fig. 4A) 
consistent with the increased expression of GPC3 
mRNA during cell differentiation observed in cell 
culture (Fig. 1). Intense staining was also noted in 
trophoblasts at the trophoblast-decidual interface (Fig. 
4E). In addition, some endometrial cells also stained 
positively for GPC3 (Fig. 4E). The identity of these cells 
has not been determined. 
GPC3 appears throughout the syncytial layer. The 
celiular staining is distributed throughout the cytoplasm 
and appears concentrated along the basal surface of the 
syncytiotrophoblast (Fig. 4A,C). Immunoblot analysis of 
plasma membranes isolated from the syncytio- 
trophoblast identified an immunoreactive species with 
molecular mass of approximately 230 kDa associated 
primarily with the fetal-facing basal membranes (Fig. 5). 
This is similar to the molecular mass of immuno-reactive 
GPC3 found in arnniotic fluid by Xu et al. (1998) using 
the same antibody preparation. Furthermore, it is similar 
to the molecular mass of GPC3 protein "shed" from the 
Caco-2 cell surface as initially described by Pilia et al. 
(1996). By contrast, the maternal-facing, microvillous 
membranes contained a less intense band migrating at 
230 kDa associated with additional lower molecular 
mass species. The identities of these immunoreactive 
species have not been confirmed. However, these 
findings are consistent with the spatial polarization of 
GPC3 on the syncytiotrophoblast cell membrane or, 
alternatively, indicative of differential processing of 
GPC3 associated with distinct regions of the cell surface. 
These data are representative of membranes derived 
from two different placentae. 
Dlscussion 
GPC3 is  a recently described member of the 
glypican family of heparan sulfate proteoglycans. 
Mutational deletions in the GPC3 gene have been shown 
to result in the Simpson-Golabi-Behmel fetal overgrowth 
syndrome (Pilia et al., 1996). Although its role in fetal 
development is unclear, it is expressed primarily in 
embryonic tissues and some tumor cells suggesting it 
serves to regulate speciñc aspects of embryonic and fetal 
development. Little is known concerning the cellular 
mechanisms by which GPC3 regulates fetal growth. 
Some insight has been obtained from recent studies 
examining the human gene product and i ts  rat 
homologue, OCI-5. The initial report of the human gene 
demonstrated its ability to bind IGF-11. This was 
subsequently confirmed by demonstrating the IGF-11 
binding properties of immunoreactive GPC3 in human 
amniotic fluid (Xu et al., 1998). This suggested a 
possible role for GPC3 in the regulation of IGF-11 by 
perhaps sequestering it or facilitating its turnover via the 
type 2 IGF receptor. SGB shares phenotypic sirnilanties 
with other fetal overgrowth syndromes such as the 
Beckwith-Wiedemann Syndrome and Perlman 
Syndrome, including the propensity for embryonal 
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Fig. 3. Localization of GPC3 transcripts in the human 
placenta. A. Term placenta hybridized with 35-S-labeled 
antisense QPC3 riboprobe. Red pixels denote specific 
hybridization to GPC3 transcripts (arrows), while blue 
staining represents nuclear DNA stained with Hoechst 
33258 (Albrecht et al., 1997). B. Term placenta 
hybridized with sense GPC3 riboprobe. Scale bar: 100 
pm for A and B. C. High magnification (x 20) of term 
human placenta hybridized with antisense GPC3 
riboprobe demonstrating the localization of transcripts to 
the syncytiotrophoblast (arrow). Scale bar: 50pm. 
tumors in certain organs (Coppin et d. ,  1997; Li et d. ,  
1998; Neri et al., 1998). The role of increased IGF-11 
production in the pathophysiology of BWS has been 
well described (Hedborg et al., 1994). It has been 
speculated that in SGB, a dismpted GPC3 gene results in 
increased levels of biologically available IGF-11 at the 
tissue leve1 resulting in organ overgrowth and tumor 
progression. Supporting this hypothesis is data obtained 
from in situ hybridization revealing the co-localization 
of IGF-11, type 2 IGF receptor, and GPC3 gene 
expression in the developing mouse (Pellegrini et al., 
1998). Interestingly, the rat homologue, OCI-5, was 
found to have binding activity towards FGF-2 but not 
IGF-11 (Song et al., 1997) suggesting that GPC3 may 
interact with severa1 growth factors but that there may be 
species differences in the binding specificity. These and 
other fundamental questions related to the basic cell 
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Flg. 4. Immunolocalization of GPC3 in tem placental tissue. A GPC3 staining is localized to the syncytiotmphoblast. An adjacent villus exhibits very 
faint siaining. x 40. B. Non-immune smm. x 40. C. Staining relaüvely strong over nuclear aggregah. x 40. D. Chorionic villi. x 20. E. Specific staining 
was present in trophoblasts at the chorion/decidual junctlon and in some endometriai cells. x 4 
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biology of GPC3 action have not been resolved. 
Given the importance of the insulin-like growth 
factors (IGFs) in regulating placental function we sought 
to identify the cell type responsible for GPC3 production 
in the placenta. This would permit us to begin to study 
its role at the cellular leve1 and investigate, specifically, 
its interaction with the IGFs and other growth factor 
signaling pathways. The results of our study demonstrate 
that GPC3 is expressed by the syncytiotrophoblast in the 
term placenta. GPC3 mRNA expression in cultured cells 
increased markedly during the differentiation of 
cytotrophoblasts to form the syncytiotrophoblast. Its 
localization to the syncytium was conñrmed by in situ 
hybridization as well as immunohistochemical 
techniques, and appears to localize preferentially to the 
basal surface of the villous syncytiotrophoblast. We have 
previously shown that the type 1 and the unoccupied type 
11 IGF receptors are located primarily on the maternal- 
facing, microvillous surface of the syncytiotrophoblast 
Flg. 5. lmrnunoblot analysis of GPC3 in placental membranes. Aliquots 
of plasma rnernbranes isolated from the fetal-facing, basal surface (B) 
and the maternal-facing, microvillous surface (M) of the 
syncytiotrophoblast were subjected to SDS-PAGE under non-reducing 
conditions and immunoblot analysis using anti-GPC3 antiserurn. 
(Fang et al., 1997). By contrast, the basal surface has 
relatively greater amounts of immunoreactive type 11 
IGF receptors that are almost al1 associated with 
phosphomannosyl-containing compounds, suggesting 
that they are actively involved in targeting proteins for 
lysosomal degradation and perhaps ongoing tissue 
turnover and remodeling. The presence of GPC3 on the 
basal surface of the syncytiotrophoblast could serve 
severa1 important functions through both IGF-dependent 
and IGF-independent pathways. GPC3 could interact 
with IGF-11 to localize them to the basal surface of the 
syncytiotrophoblast. There they could regulate 
trophoblast growth and metabolic function directly or, 
alternatively, regulate cell function in the stromal 
compartment via paracrine mechanisms by modulating 
the levels of IGF-11 in the local environment. 
Interestingly, IGF-11 is produced primarily by the 
stromal cells and is the predominant IGF present in the 
villous core (Wang et al., 1988). This would make it 
readily accessible to GPC3 on the basal membrane 
surface. In addition, a variety of peptide growth factors 
have been shown to bind to heparan-sulfate 
proteoglycans (HSPG) which serve to modulate their 
biologic activity, including fibroblast growth factor 
(FGF-2), hepatocyte growth factor (HGF), placental 
growth factor (PlGF), and heparin-binding epidermal 
growth factor-like factor (HB-EGF) (Song et al., 1997; 
Arkonac et al., 1998; Athanassiades and Lala, 1998; 
Hartmann et al., 1998; Lambrecht et al., 1998). These 
peptides presumably play significant roles in regulating 
both trophoblast growth and mesenchymal cell growth. 
The specificity of growth factor binding to GPC3, as 
well as the factors that influence its specificity, have not 
been characterized. The demonstrated associations of 
GPC-3 with IGF-11 and its rat homologue with FGF-2, 
however, suggests that it may play multifunctional roles 
in regulating the trophoblast as well as activity within 
the stromal compartment, including angiogenesis and/or 
endothelial cell migration. 
Finally, a recent study demonstrated that GPC3 
expression induces apoptosis in a cell-type dependent 
manner (Gonzalez et al., 1998). A role for IGFs in 
protecting cells from apoptosis has been demonstrated in 
a variety of cell types (Baserga et al., 1997; 07Connor et 
al., 1997). It is intriguing to speculate that the 
coordinated expression of IGFs and GPC3 may also play 
a role in regulating the total cellular mass of the 
syncytiotrophoblast by influencing the cell's 
susceptibility to apoptotic stimuli. 
In summary GPC3 is expressed primarily by 
embryonic tissues and has been shown to be necessary 
for normal fetal growth. We have demonstrated that it is 
expressed by the differentiated syncytiotrophoblast in the 
human placenta at term. GPC3 is therefore likely to 
regulate fetal growth, in part, by playing a significant 
role in placental development andlor function. Studies 
are currently underway to define the expression of GPC3 
throughout gestation in normal and abnormal 
pregnancies. 

